Articles Tagged With: Abortion
-
Assessing the Availability of Procedural, Later Abortion Services Pre- and Post-Dobbs
From 2021 to 2023, the number of publicly advertising procedural abortion facilities in the United States decreased 11%. Of those that persisted, 28% of facilities decreased their gestational age limits and 21% increased their gestational age limits.
-
Trends in Contraceptive Use Among Abortion Patients
In this cross-sectional study of 88,550 patients presenting for abortion services in England and Wales in 2018 and 2023, the use of effective methods of contraception decreased over time (hormonal methods: 18.8% vs. 11.3%, P < 0.001; long-acting reversible contraceptives: 3% vs. 0.6%, P < 0.001), while fertility awareness-based methods increased from 0.4% to 2.5% (P < 0.001).
-
Abortion Training Increasingly Affected by Dobbs Decision
OB/GYN abortion training programs have been negatively affected by logistical and financial burdens in the nearly three years since the U.S. Supreme Court overturned Roe v. Wade and universal abortion access rights with its decision in Dobbs v. Jackson Women’s Health Organization on June 24, 2022.
-
Fewer Facilities Offer Procedural Abortion After Dobbs Decision
The number of publicly advertising abortion facilities that provide procedural abortions dropped by 11% from 2021 to 2023, a new study finds.
-
Abortion Access and Pregnancy Dangers Continue
This issue will look at some of the repercussions of the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization and hear from providers and researchers on what can be done to mitigate the damage to their patients’ health and lives.
-
Placenta Accreta Spectrum Among Patients Seeking Abortion
Placenta accreta spectrum (PAS) in patients seeking abortions poses significant risks, especially for those with prior cesarean deliveries. PAS, often related to prior cesarean deliveries, increases abortion-related complications. Ultrasound is key for detection, but access to skilled care may be limited because of state-based abortion restrictions, leading to worse outcomes for affected patients.
-
U.S. Supreme Court’s Decision on Emergency Abortions Raises More Questions than Answers
The big question for OB/GYNs, emergency department (ED) physicians, and the reproductive healthcare community is whether the U.S. Supreme Court’s decision on June 27, 2024, in the case of Idaho and Moyle v. United States, will change emergency care for pregnant women in the United States.
-
What Did Supreme Court Justices Say About EMTALA and Abortion?
By the end of June, the U.S. Supreme Court will decide on whether Idaho and other states can require hospitals — through criminal laws — to turn away pregnant women experiencing a major health crisis when the best treatment for them is an abortion to end their pregnancy. Idaho presented a case that their state law preempts the Emergency Medical Treatment and Active Labor Act (EMTALA), and the federal government argued that EMTALA and the mission of protecting patients’ health and lives takes precedence.
-
U.S. Supreme Court Unanimously Rejected Lawsuit Challenging FDA’s Mifepristone Decisions
Reproductive healthcare and abortion providers can exhale in relief — however briefly — because a unanimous U.S. Supreme Court decision maintains telehealth access to mifepristone, an abortion drug, in the United States.
-
Researchers: Studies Cited in Court Cases on Abortion and Mental Health Impact Are Flawed
As the U.S. Supreme Court considers a case involving the abortion medication mifepristone and whether it was properly approved by the Food and Drug Administration, justices will see mention of research about abortion from flawed studies, including some that have been retracted.